MedTrace Logo

Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)

NCT02558595 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2019-02-11

No results posted yet for this study

Summary

The purpose of this study is to observe the effects of niacinamide on markers of kidney injury, inflammation, kidney cyst growth and kidney function.

Conditions

  • Polycystic Kidney Disease

Interventions

DIETARY_SUPPLEMENT

Niacinamide

OTHER

Placebo

Placebo pill that matches niacinamide pill is size, shape and color

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Alan Yu, M.B., B.Chir · University of Kansas Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-22
Primary Completion
2017-12-18
Completion
2017-12-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02558595 on ClinicalTrials.gov